Recombinant human CD19L-sTRAIL effectively targets B cell precursor acute lymphoblastic leukemia.
about
Low Dose Total Body Irradiation Combined With Recombinant CD19-Ligand × Soluble TRAIL Fusion Protein is Highly Effective Against Radiation-Resistant B-Precursor Acute Lymphoblastic Leukemia in MiceDevelopment of Polypeptide-based Nanoparticles for Non-viral Delivery of CD22 RNA Trans-splicing Molecule as a New Precision Medicine Candidate Against B-lineage ALL.Liposomal Nanoparticles of a Spleen Tyrosine Kinase P-Site Inhibitor Amplify the Potency of Low Dose Total Body Irradiation Against Aggressive B-Precursor Leukemia and Yield Superior Survival Outcomes in MiceIntracellular Signaling Pathways Involved in Childhood Acute Lymphoblastic Leukemia; Molecular Targets
P2860
Recombinant human CD19L-sTRAIL effectively targets B cell precursor acute lymphoblastic leukemia.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Recombinant human CD19L-sTRAIL ...... acute lymphoblastic leukemia.
@ast
Recombinant human CD19L-sTRAIL ...... acute lymphoblastic leukemia.
@en
type
label
Recombinant human CD19L-sTRAIL ...... acute lymphoblastic leukemia.
@ast
Recombinant human CD19L-sTRAIL ...... acute lymphoblastic leukemia.
@en
prefLabel
Recombinant human CD19L-sTRAIL ...... acute lymphoblastic leukemia.
@ast
Recombinant human CD19L-sTRAIL ...... acute lymphoblastic leukemia.
@en
P2093
P2860
P356
P1476
Recombinant human CD19L-sTRAIL ...... acute lymphoblastic leukemia.
@en
P2093
Dorothea E Myers
Osmond J D'Cruz
Rebecca Rose
Sanjive Qazi
Zahide Ozer
P2860
P304
P356
10.1172/JCI76610
P407
P577
2015-01-26T00:00:00Z